Early T1D Detection and Clinical Trials

Early detection of type 1 diabetes (T1D) is key to ensuring faster diagnosis, preventing serious complications, and opening access to prevention trials or, in some countries, newly approved therapies that can delay disease onset. With the support of its strategic supporters, INNODIA has launched a pan-European program enabling early T1D detection across its network. Here, both clinical centers and individuals interested in screening or monitoring for pre-symptomatic T1D can find essential information and resources.